Related references
Note: Only part of the references are listed.Outcome of patients with de novo versus nevus-associated melanoma
William M. Lin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Nevus-Associated Melanomas: Clinicopathologic Features
Danielle Shitara et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Multiple Primary Acral Melanomas in Two Young Caucasian Patients
Goretti Lacruz et al.
DERMATOLOGY (2014)
Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas
Hojabr Kakavand et al.
PATHOLOGY (2014)
Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
Veronica A. Kinsler et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Clonal BRAF Mutations in Melanocytic Nevi and Initiating Role of BRAF in Melanocytic Neoplasia
Iwei Yeh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
Maria Colombino et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi
Philipp Tschandl et al.
PLOS ONE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Nodal Melanoma Metastasis under Infliximab Therapy in a Patient with Nevoid Melanoma First Misdiagnosed as Benign Nevus: A Potentially Dangerous Diagnostic Pitfall in the Era of Biologic Therapies
Gilles Safa et al.
CASE REPORTS IN DERMATOLOGY (2013)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Liesbeth C. W. Vredeveld et al.
GENES & DEVELOPMENT (2012)
Association of activated c-Met with NRAS-mutated human melanomas: a possible avenue for targeting
Chandrani Chattopadhyay et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome
Giovanni Ponti et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Biological evaluation of MR36, a novel non-polyglutamatable thymidylate synthase inhibitor that blocks cell cycle progression in melanoma cell lines
Stefania Giudice et al.
INVESTIGATIONAL NEW DRUGS (2012)
Melanoma: New Insights and New Therapies
Vasiliki A. Nikolaou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
Reviewing the somatic genetics of melanoma: from current to future analytical approaches
Ken Dutton-Regester et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin
David C. Whiteman et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Clues to the diagnosis of atypical melanocytic lesions
Phillip H. McKee
HISTOPATHOLOGY (2010)
Melanoma in association with acquired melanocytic nevus in Japan: a review of cases in the literature
Y. Togawa et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Malignant melanoma transformation within a nevus of Ito
Sean R. Wise et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center
B. Aika Shoo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma
Minoru Takata et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis
O. E. Dadzie et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma
Matthew W. VanBrocklin et al.
CANCER RESEARCH (2009)
Applications of Genomics in Melanoma Oncogene Discovery
Michael F. Berger et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Genotypic and Gene Expression Studies in Congenital Melanocytic Nevi: Insight into Initial Steps of Melanotumorigenesis
Barbara Dessars et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Complications of congenital melanocytic naevi in children: analysis of 16 years' experience and clinical practice
V. A. Kinsler et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Melanoma Genetics and Therapeutic Approaches in the 21st Century: Moving from the Benchside to the Bedside
Thomas L. Hocker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
BRAFE600 in benign and malignant human tumours
C. Michaloglou et al.
ONCOGENE (2008)
Genetics of melanoma tumorigenesis
M. Singh et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Number of Nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma
Nancy E. Thomas et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Melanomas arising from naevi and de novo melanomas - does origin matter?
S. C. Weatherhead et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity
Carlotta Petti et al.
CANCER RESEARCH (2006)
Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma
M. Sensi et al.
ONCOGENE (2006)
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
Vikas K. Goel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma
MP Purdue et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Large or multiple congenital melanocytic nevi: Occurrence of cutaneous melanoma in 1008 persons
BJ Bett
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues
MR Hussein
JOURNAL OF CLINICAL PATHOLOGY (2005)
Detection of B-RAF and N-RAS mutations in human melanoma
JS Goydos et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Congenital melanocytic nevi: Clinical and histopathologic features, risk of melanoma, and clinical management
ZS Tannous et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
Invasive superficial spreading melanomas arising from clinically normal skin
NE Thomas et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
p16INK4A expression in malignant melanomas with or without a contiguous naevus remnant:: a clue to their divergent pathogenesis?
V Winnepenninckx et al.
MELANOMA RESEARCH (2004)
Genetic pathways to melanoma tumorigenesis
MR Hussein
JOURNAL OF CLINICAL PATHOLOGY (2004)
Classification of congenital melanocytic naevi and malignant transformation: a review of the literature
LH Zaal et al.
BRITISH JOURNAL OF PLASTIC SURGERY (2004)
Risk of melanoma arising in large congenital melanocytic nevi: A systematic review
AJ Watt et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2004)
Activating BRAF and N-Ras mutations in sporadic primary melanomas:: an inverse association with allelic loss on chromosome 9
R Kumar et al.
ONCOGENE (2003)
Determinants of BRAF mutations in primary melanomas
JL Maldonado et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Cutaneous melanomas associated with nevi
C Bevona et al.
ARCHIVES OF DERMATOLOGY (2003)
Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma
DC Whiteman et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Melanoma ex naevo:: a study of the associated naevus
I Bogdan et al.
MELANOMA RESEARCH (2003)
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma - A population-based estimate
H Tsao et al.
ARCHIVES OF DERMATOLOGY (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Mutations of the BRAF gene in benign and malignant melanocytic lesions
AS Yazdi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Tumorigenesis -: RAF/RAS oncogenes and mismatch-repair status
H Rajagopalan et al.
NATURE (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis
S Kaddu et al.
MELANOMA RESEARCH (2002)
Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma
A Demunter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Problematic pigmented lesions: approach to diagnosis
SL Edwards et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
